C.M. Bidwell & Associates’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,143
Closed -$85K 557
2021
Q4
$85K Buy
+1,143
New +$85K 0.05% 249